Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Neogen Chemicals
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Neogen Chemicals

WEBSITE BSE:542665 NSE: NEOGEN Inc. Year: 1989 Industry: Chemicals My Bucket: Add Stock

₹1508.5 13.8 | 0.9%

Last updated: 15:57

Consolidated Standalone

Last updated: 15:57

Neogen Chemicals Overview

Neogen Chemicals Ltd manufactures and sells speciality chemical substances in India. It gives organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and different compounds; inorganic bromine compounds and lithium salts; grignard reagents; and inter...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Neogen Chemicals Key Financials

Market Cap ₹4131 Cr.

Stock P/E 118.6

P/B 5

Current Price ₹1508.5

Book Value ₹ 304.5

Face Value 10

52W High ₹1788

Dividend Yield 0.07%

52W Low ₹ 978

Edit Ratio

Neogen Chemicals Share Price

₹ | |

Volume
Price

Neogen Chemicals Quarterly Price

Quarterly Monthly
Show Value Show %

Neogen Chemicals Peer Comparison

Neogen Chemicals Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 162 164 200 180 193 201 203 187 209 220
Other Income 2 2 2 2 1 1 1 1 2 2
Total Income 164 166 202 182 194 202 203 188 211 222
Total Expenditure 136 144 164 149 159 167 166 155 179 188
Operating Profit 28 22 38 32 35 36 37 33 32 34
Interest 11 11 10 10 13 13 13 13 19 22
Depreciation 6 6 6 7 7 7 7 6 7 7
Exceptional Income / Expenses 0 0 0 0 0 0 -14 0 0 0
Profit Before Tax 11 6 22 16 15 15 4 14 5 6
Provision for Tax 3 5 6 4 5 5 1 4 2 2
Profit After Tax 8 1 17 11 11 10 2 10 3 4
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 8 1 17 11 11 10 2 10 3 4
Adjusted Earnings Per Share 3.2 0.4 6.4 4.3 4.2 3.8 0.9 3.9 1.3 1.4

Neogen Chemicals Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 84 100 110 161 239 306 336 487 686 691 778 819
Other Income 1 0 0 1 1 0 0 1 4 7 4 6
Total Income 85 100 110 162 240 306 337 488 691 698 782 824
Total Expenditure 71 86 90 132 196 248 272 401 575 581 641 688
Operating Profit 14 14 20 30 44 58 65 88 116 118 140 136
Interest 5 5 8 10 12 12 14 19 29 42 49 67
Depreciation 1 1 1 2 3 5 7 12 16 23 28 27
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 -14 -14
Profit Before Tax 8 8 11 17 29 41 44 57 71 53 50 29
Provision for Tax 3 3 4 6 8 12 13 12 21 17 15 9
Profit After Tax 5 5 8 11 21 29 31 45 50 36 35 19
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 5 5 8 11 21 29 31 45 50 36 35 19
Adjusted Earnings Per Share 2.5 2.6 3.8 5.5 10.4 12.3 13.4 17.9 20 13.5 13.2 7.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 13% 17% 21% 25%
Operating Profit CAGR 19% 17% 19% 26%
PAT CAGR -3% -8% 4% 21%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -8% -2% 12% NA%
ROE Average 5% 7% 11% 19%
ROCE Average 8% 10% 12% 19%

Neogen Chemicals Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 23 28 42 50 70 156 183 439 483 760 789
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 5 5 37 38 51 30 116 122 129 124 170
Other Non-Current Liabilities 3 3 7 8 9 18 15 20 32 50 54
Total Current Liabilities 38 46 67 84 117 150 178 218 410 527 733
Total Liabilities 69 80 152 180 246 355 492 799 1054 1461 1747
Fixed Assets 13 17 56 67 83 111 127 285 347 496 404
Other Non-Current Assets 2 2 6 7 4 13 125 22 51 182 344
Total Current Assets 53 61 90 107 160 231 240 492 656 784 1000
Total Assets 69 80 152 180 246 355 492 799 1054 1461 1747

Neogen Chemicals Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 2 2 3 2 2 1 1 45 21 13
Cash Flow from Operating Activities 9 9 0 12 -4 -35 84 1 -30 -29 196
Cash Flow from Investing Activities -2 -4 -33 -13 -20 -29 -135 -146 -94 -216 -317
Cash Flow from Financing Activities -6 -4 33 -0 24 63 51 188 100 237 113
Net Cash Inflow / Outflow 1 0 1 -1 0 -1 -0 44 -25 -8 -8
Closing Cash & Cash Equivalent 2 2 3 2 2 1 1 45 21 13 5

Neogen Chemicals Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.55 2.59 3.84 5.49 10.43 12.28 13.43 17.89 20.04 13.51 13.2
CEPS(Rs) 3.01 3.09 4.48 6.42 11.85 14.53 16.39 22.58 26.53 22.18 23.74
DPS(Rs) 2 0.45 0 1 1.5 2 2.25 2.75 3 2 1
Book NAV/Share(Rs) 11.76 13.77 20.98 25.21 34.96 66.96 78.44 176.12 193.47 288.21 299.24
Core EBITDA Margin(%) 13.84 12.96 16.45 17.68 16.99 16.7 16.06 17.77 16.27 15.83 17.44
EBIT Margin(%) 13.9 12.19 15.63 16.98 16.12 15.25 14.47 15.63 14.57 13.64 12.62
Pre Tax Margin(%) 8.82 7.79 9.44 10.62 11.45 11.82 11.03 11.71 10.35 7.59 6.42
PAT Margin (%) 5.56 4.76 6.29 6.7 8.2 8.24 7.82 9.16 7.28 5.13 4.46
Cash Profit Margin (%) 6.58 5.68 7.37 7.83 9.31 9.75 9.54 11.56 9.64 8.42 8.01
ROA(%) 7.72 6.94 6.57 6.6 9.81 9.53 7.4 6.91 5.39 2.83 2.17
ROE(%) 23.61 20.3 22 23.78 34.73 25.31 18.47 14.34 10.84 5.74 4.5
ROCE(%) 27.42 26.11 23.01 22.85 25.52 21.93 16.75 14.33 13.25 9.49 7.86
Receivable days 68.93 56.68 72.13 81.81 72.86 71.35 70.02 70.43 76.3 120.51 112.52
Inventory Days 90.82 93.95 107.83 100.15 87.39 106.19 111.05 115.59 129.67 177.31 161.47
Payable days 112.7 114.11 150.54 130.19 103.11 77.99 94.13 109.49 119.98 143.69 175.91
PER(x) 0 0 0 0 0 28.59 64.36 97.51 64.03 88.26 117.02
Price/Book(x) 0 0 0 0 0 5.24 11.02 9.91 6.63 4.14 5.16
Dividend Yield(%) 0 0 0 0 0 0.57 0.26 0.16 0.23 0.17 0.06
EV/Net Sales(x) 0.31 0.44 0.78 0.62 0.58 3.12 6.63 9.3 5.16 5.11 5.96
EV/Core EBITDA(x) 1.93 3.08 4.24 3.39 3.14 16.42 34.59 51.69 30.51 30.02 33.04
Net Sales Growth(%) 13.7 19.52 9.74 46.41 48.34 28.05 9.89 44.84 40.83 0.65 12.58
EBIT Growth(%) 16.01 4.35 43.04 46.66 47.95 28.72 9.35 31.34 31.28 -5.14 4.04
PAT Growth(%) 39.58 1.87 47.59 43.68 90.7 36.81 9.33 42.45 11.97 -28.66 -2.3
EPS Growth(%) 39.58 1.77 48.32 42.97 89.94 17.72 9.35 33.25 11.97 -32.55 -2.3
Debt/Equity(x) 1.03 0.96 1.65 1.63 1.71 0.88 1.18 0.51 0.75 0.52 0.72
Current Ratio(x) 1.4 1.34 1.35 1.28 1.37 1.54 1.35 2.26 1.6 1.49 1.36
Quick Ratio(x) 0.76 0.64 0.75 0.68 0.75 0.68 0.71 1.36 0.89 0.76 0.94
Interest Cover(x) 2.73 2.77 2.53 2.67 3.45 4.45 4.21 3.99 3.45 2.25 2.03
Total Debt/Mcap(x) 0 0 0 0 0 0.17 0.11 0.05 0.11 0.13 0.14

Neogen Chemicals Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 56.89 56.89 56.89 51.23 51.23 51.23 51.23 51.23 51.23 51.23
FII 4.51 4.56 4.65 8.17 7.73 7.79 7.36 5.15 4.57 4.46
DII 22.84 22.14 22.54 22.48 22.53 22.75 22.96 25.23 21.99 22.64
Public 15.75 16.41 15.92 18.12 18.51 18.23 18.45 18.39 22.21 21.67
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Neogen Chemicals News

Neogen Chemicals Pros & Cons

Pros

Cons

  • Company has a low return on equity of 7% over the last 3 years.
  • Debtor days have increased from 143.69 to 175.91days.
  • Stock is trading at 5 times its book value.
  • The company has delivered a poor profit growth of 3% over past five years.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!